These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

294 related items for PubMed ID: 4045199

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Characterization and distribution in human tissues of a glycoproteic antigen defined by monoclonal antibody 1BE12 raised against the human breast cancer cell line T47D.
    Pancino G, Charpin C, Osinaga E, Betaille B, Le Roy M, Calvo F, Roseto A.
    Cancer Res; 1990 Nov 15; 50(22):7333-42. PubMed ID: 2224861
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Oligosaccharide differences in the DF3 sialomucin antigen from normal human milk and the BT-20 human breast carcinoma cell line.
    Hull SR, Bright A, Carraway KL, Abe M, Hayes DF, Kufe DW.
    Cancer Commun; 1989 Nov 15; 1(4):261-7. PubMed ID: 2639730
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. The breast tumor-associated epitope defined by monoclonal antibody 3E1.2 is an O-linked mucin carbohydrate containing N-glycolylneuraminic acid.
    Devine PL, Clark BA, Birrell GW, Layton GT, Ward BG, Alewood PF, McKenzie IF.
    Cancer Res; 1991 Nov 01; 51(21):5826-36. PubMed ID: 1718585
    [Abstract] [Full Text] [Related]

  • 11. Expression of tumor-associated antigen (DF3) in atypical hyperplasias and in situ carcinomas of the human breast.
    Ohuchi N, Page DL, Merino MJ, Viglione MJ, Kufe DW, Schlom J.
    J Natl Cancer Inst; 1987 Jul 01; 79(1):109-17. PubMed ID: 3298784
    [Abstract] [Full Text] [Related]

  • 12. Tumor selective reactivity of a monoclonal antibody prepared against a recombinant peptide derived from the DF3 human breast carcinoma-associated antigen.
    Perey L, Hayes DF, Maimonis P, Abe M, O'Hara C, Kufe DW.
    Cancer Res; 1992 May 01; 52(9):2563-8. PubMed ID: 1373671
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Phagocytosis of breast cancer cells mediated by anti-MUC-1 monoclonal antibody, DF3, and its bispecific antibody.
    Akewanlop C, Watanabe M, Singh B, Walker M, Kufe DW, Hayes DF.
    Cancer Res; 2001 May 15; 61(10):4061-5. PubMed ID: 11358826
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Purification and composition of a novel gastrointestinal tumor-associated glycoprotein expressing sialylated lacto-N-fucopentaose II (CA 19-9).
    Klug TL, LeDonne NC, Greber TF, Zurawski VR.
    Cancer Res; 1988 Mar 15; 48(6):1505-11. PubMed ID: 2449952
    [Abstract] [Full Text] [Related]

  • 20. Effects of differentiating agents on cell surface expression of the breast carcinoma-associated DF3-P epitope.
    Perey L, Hayes DF, Kufe D.
    Cancer Res; 1992 Nov 15; 52(22):6365-70. PubMed ID: 1384960
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.